Clinical Trial Update: A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating combinations of vedolizumab IV with adalimumab or vedolizumab with ustekinumab in adults with Crohn's disease. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• USTEKINUMAB (USTEKINUMAB)
• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Crohn's Disease | Phase 4 | Status: RECRUITING